Jyong Biotech Ltd. Ordinary Shares

NASDAQ:MENS

Biotechnology

Healthcare
$1.86 -1.41%

-$0.02 today

Market cap
$141.41M
Beta
2.08
P/E (TTM)
-25.1
EPS (TTM)
-$0.06
52W Low $1.43High $67.00

Volume 0.07M

Average 0.10M

Fair Value & DCF

Compare our fair value with your own assumptions

Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.

Jyong Biotech Ltd. Ordinary Shares

NASDAQ:MENS

Intrinsic Alpha fair value

Locked

Current Price

$1.86

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.

Build your own valuation

Test an independent scenario and compare it with Intrinsic Alpha's estimate.

Sign in to use the DCF calculator

Free accounts get 5 valuations per week. Upgrade for more.

Sign in / Sign up

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A —
RevenueN/AN/AN/A
N/A —
Net IncomeN/AN/AN/A
N/A —
EBITN/AN/AN/A
N/A —

Analysis

Analysis will appear once historical growth or forward estimates are available for this company.

Estimates & History

Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.

Competitor Valuations

Peer stocks ranked by intrinsic value status

CompanyMarket CapPriceValuationP/E1Y Return

Apogee Therapeutics, Inc.

NASDAQ:APGE

$8.40B$135.07Not rated-22.7+111.61%

CG Oncology, Inc. Common stock

NASDAQ:CGON

$6.65B$74.40Not rated-28.0+87.79%

Centessa Pharmaceuticals plc

NASDAQ:CNTA

$6.27B$40.50Not rated-24.4+44.64%

Travere Therapeutics, Inc.

NASDAQ:TVTX

$4.86B$50.65Overvalued-235.0+41.80%

Xenon Pharmaceuticals Inc.

NASDAQ:XENE

$3.98B$40.48Not rated-12.1-7.13%

Legend Biotech Corporation

NASDAQ:LEGN

$3.24B$17.50Not rated-21.4-41.96%

Dyne Therapeutics, Inc.

NASDAQ:DYN

$3.22B$17.16Not rated-7.2-22.96%

Celcuity Inc.

NASDAQ:CELC

$3.15B$64.37Not rated-23.7-41.00%

Ultragenyx Pharmaceutical Inc.

NASDAQ:RARE

$1.64B$16.08Not rated-4.6-44.35%

Ascentage Pharma Group International

NASDAQ:AAPG

$339.78M$14.62Not rated-8.9-59.59%